Executive SummarySteatosis Imaging
Executive Summary • Hepatic Steatosis Imaging

Imaging-Based Diagnostic Tests in MASH: Tests to Assess Liver Fat

Executive comparison of quantitative ultrasound attenuation (eg, CAP) and MRI Proton Density Fat Fraction (MRI-PDFF) for measuring hepatic steatosis.

What This Means for Patients

When you get a FibroScan, the CAP number (measured in dB/m, often flagged at 288 dB/m or above) estimates how much fat is stored in your liver, whereas MRI-PDFF gives an exact fat percentage across the liver (5% or higher indicates elevated liver fat). Keep in mind that different ultrasound brands use different scales, so it's best to compare follow-up scans done on the same type of machine.

Test Cutoffs Strengths Limitations
Ultrasound attenuation Cutoff values are dependent on the specific instrument1

eg, CAP™a ≥288 dB/m indicates elevated liver fat2,3
  • Noninvasive quantifiable estimate of liver fat4
  • Good diagnostic accuracy with established cutoffs per instrument, sensitivity, and specificity3,4
  • Measurements scale/output can vary across imaging platforms5
  • Accuracy can be affected by technical factors such as transducer frequency and gain settings6
MRI-PDFF ≥5% suggests elevated liver fat2
  • Accurate and reproducible across all grades of steatosis7
  • Requires specialized vendor-specific software8
  • Accuracy depends on ROI; whole-liver averages preferred for consistent tracking9